Getting rid of refractory hemophilia
- PMID: 22323405
- DOI: 10.1182/blood-2011-12-394429
Getting rid of refractory hemophilia
Abstract
In a prospective randomized, multicenter study of immune tolerance induction(ITI) in patients with hemophilia A refractory to replacement therapy after the development of alloantibodies that inhibit factor VIII (FVIII) activity, Hay and DiMichele compared two regimens, a low dose of FVIII (50 IU/Kg thrice weekly)or a high-dose (200 IU/kg daily
Comment on
-
The principal results of the International Immune Tolerance Study: a randomized dose comparison.Blood. 2012 Feb 9;119(6):1335-44. doi: 10.1182/blood-2011-08-369132. Epub 2011 Nov 18. Blood. 2012. PMID: 22101900 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources

